Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Scharnagl

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
FEBS Letters|September 13, 2017
FXR controls CHOP expression in steatohepatitisClaudia D Fuchs, Thierry Claudel, Hubert Scharnagl, et al.
European Journal of Preventive Cardiology|April 25, 2017
Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health studyGünther Silbernagel, Hubert Scharnagl, Marcus E Kleber, et al.
Peptides|April 24, 2018
Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fractionIngrid Gergei, Bernhard K Krämer, Hubert Scharnagl, et al.
Biochemical Pharmacology|December 19, 2009
Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathyPeter James Mullen, Barbara Lüscher, Hubert Scharnagl, et al.
Clinical Chemistry and Laboratory Medicine|March 18, 2015
Reference ranges of serum bile acids in children and adolescentsJörg Jahnel, Evelyn Zöhrer, Hubert Scharnagl, et al.
Cardiology|May 13, 2006
Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administrationHubert Scharnagl, Monika Vogel, Claudia Abletshauser, et al.
Deutsches Arzteblatt International|November 18, 2015
Treatment Options for Statin-Associated Muscle SymptomsUlrich Laufs, Hubert Scharnagl, Martin Halle, et al.
Medicine|October 22, 2021
Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case reportAdrienn Tünnemann-Tarr, Hubert Scharnagl, Julius L Katzmann, et al.
Aging|September 8, 2019
Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health studyIrene Pusceddu, Wolfgang Herrmann, Marcus E Kleber, et al.
Contraception|February 5, 2004
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolismHubert Scharnagl, Gudula Petersen, Matthias Nauck, et al.
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
FEBS Letters|September 13, 2017
FXR controls CHOP expression in steatohepatitisClaudia D Fuchs, Thierry Claudel, Hubert Scharnagl, et al.
European Journal of Preventive Cardiology|April 25, 2017
Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health studyGünther Silbernagel, Hubert Scharnagl, Marcus E Kleber, et al.
Peptides|April 24, 2018
Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fractionIngrid Gergei, Bernhard K Krämer, Hubert Scharnagl, et al.
Biochemical Pharmacology|December 19, 2009
Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathyPeter James Mullen, Barbara Lüscher, Hubert Scharnagl, et al.
Clinical Chemistry and Laboratory Medicine|March 18, 2015
Reference ranges of serum bile acids in children and adolescentsJörg Jahnel, Evelyn Zöhrer, Hubert Scharnagl, et al.
Cardiology|May 13, 2006
Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administrationHubert Scharnagl, Monika Vogel, Claudia Abletshauser, et al.
Deutsches Arzteblatt International|November 18, 2015
Treatment Options for Statin-Associated Muscle SymptomsUlrich Laufs, Hubert Scharnagl, Martin Halle, et al.
Medicine|October 22, 2021
Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case reportAdrienn Tünnemann-Tarr, Hubert Scharnagl, Julius L Katzmann, et al.
Aging|September 8, 2019
Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health studyIrene Pusceddu, Wolfgang Herrmann, Marcus E Kleber, et al.
Contraception|February 5, 2004
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolismHubert Scharnagl, Gudula Petersen, Matthias Nauck, et al.
Pageof 25